Preventing clinically important deterioration with single-inhaler triple therapy in COPD

Clinically important deterioration (CID) is a novel composite end-point (lung function, health status, exacerbations) for assessing disease stability in patients with chronic obstructive pulmonary disease (COPD). We prospectively analysed CID in the FULFIL study. FULFIL (ClinicalTrials.gov NCT023451...

Descripción completa

Detalles Bibliográficos
Autores principales: Naya, Ian, Compton, Chris, Ismaila, Afisi S., Birk, Ruby, Brealey, Noushin, Tabberer, Maggie, Zhu, Chang-Qing, Lipson, David A., Criner, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168763/
https://www.ncbi.nlm.nih.gov/pubmed/30302335
http://dx.doi.org/10.1183/23120541.00047-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168763/
https://www.ncbi.nlm.nih.gov/pubmed/30302335
http://dx.doi.org/10.1183/23120541.00047-2018

Ejemplares similares